Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Natanson

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Experimental Medicine|March 1, 1989
Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shockC Natanson, P W Eichenholz, R L Danner, et al.
The Journal of Clinical Investigation|January 1, 1989
Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shockC Natanson, R L Danner, R J Elin, et al.
The Journal of Infectious Diseases|February 1, 1993
Therapeutic trial of lipid X in a canine model of septic shockR L Danner, P Q Eichacker, M E Doerfler, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 15, 2001
Acute G-CSF therapy is not protective during lethal E. coli sepsisZ Quezado, C Parent, W Karzai, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 6, 1998
Cardiopulmonary effects of inhaled nitric oxide in normal dogs and during E. coli pneumonia and sepsisZ M Quezado, C Natanson, W Karzai, et al.
The Journal of Experimental Medicine|October 1, 1992
N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxinJ P Cobb, C Natanson, W D Hoffman, et al.
Critical Care Medicine|May 20, 1998
Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in caninesB D Freeman, F Zeni, S M Banks, et al.
The American Journal of Physiology|November 1, 1990
Antibiotics versus cardiovascular support in a canine model of human septic shockC Natanson, R L Danner, J M Reilly, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 20, 1999
ICAM-1 and CD11b inhibition worsen outcome in rats with E. coli pneumoniaF Zeni, C Parent, R Correa, et al.
JAMA|May 5, 1993
A controlled trial of HA-1A in a canine model of gram-negative septic shockZ M Quezado, C Natanson, D W Alling, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Experimental Medicine|March 1, 1989
Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shockC Natanson, P W Eichenholz, R L Danner, et al.
The Journal of Clinical Investigation|January 1, 1989
Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shockC Natanson, R L Danner, R J Elin, et al.
The Journal of Infectious Diseases|February 1, 1993
Therapeutic trial of lipid X in a canine model of septic shockR L Danner, P Q Eichacker, M E Doerfler, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 15, 2001
Acute G-CSF therapy is not protective during lethal E. coli sepsisZ Quezado, C Parent, W Karzai, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 6, 1998
Cardiopulmonary effects of inhaled nitric oxide in normal dogs and during E. coli pneumonia and sepsisZ M Quezado, C Natanson, W Karzai, et al.
The Journal of Experimental Medicine|October 1, 1992
N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxinJ P Cobb, C Natanson, W D Hoffman, et al.
Critical Care Medicine|May 20, 1998
Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in caninesB D Freeman, F Zeni, S M Banks, et al.
The American Journal of Physiology|November 1, 1990
Antibiotics versus cardiovascular support in a canine model of human septic shockC Natanson, R L Danner, J M Reilly, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 20, 1999
ICAM-1 and CD11b inhibition worsen outcome in rats with E. coli pneumoniaF Zeni, C Parent, R Correa, et al.
JAMA|May 5, 1993
A controlled trial of HA-1A in a canine model of gram-negative septic shockZ M Quezado, C Natanson, D W Alling, et al.
Pageof 7